Targeted Video Messaging About Emergency Contraception

Targeted Video Messaging About Emergency Contraception Via a Social Media Platform

This research study will assess the real-world effectiveness of Facebook advertising as a strategy to reach women of reproductive age who are at risk of unintended pregnancy with a brief educational intervention about emergency contraception (EC).

Study Overview

• Status: Completed
• Conditions: Contraception
• Intervention / Treatment: Other: Emergency contraception website; Other: Emergency contraception video

Detailed Description

This research study will assess the real-world effectiveness of Facebook advertising as a strategy to reach women of reproductive age who are at risk of unintended pregnancy with a brief educational intervention about emergency contraception (EC). The investigators will assess whether a video or website link has superior reach, engagement, and return on investment (measured as cost per click) through a Facebook ad campaign. The investigators will also ensure that both modalities of consumer engagement (website and video) are efficacious at ensuring adequate and improved knowledge of emergency contraception through a laboratory-environment trial.

• Study Type: Interventional
• Enrollment (Actual): 150
• Phase: Not Applicable

Contacts and Locations

Study Locations

• United States
  • Massachusetts
    • Boston, Massachusetts, United States, 02215
      • PPLM

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years to 29 years (Adult)
• Accepts Healthy Volunteers: Yes
• Genders Eligible for Study: Female

Description

Inclusion Criteria:

• Women
• 18 to 29 years old
• Living or seeking care in or around Boston, MA
• Able to participate in an in-person visit at Planned Parenthood League of Massachusetts (PPLM) Boston Health Center
• English fluency
• Have at least one social media account (i.e. Facebook, Instagram, Twitter, Pinterest, YouTube, Snapchat)
• Endorse using social media at least once a week

Exclusion Criteria:

• PPLM staff
• Currently or ever employed in the reproductive health field
• Currently using long-acting reversible contraception (LARC)
• History of permanent sterilization (by participant or sexual partner)
• Previous participation in the study

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Other
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: None (Open Label)

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Other: Website about emergency contraception; Subjects are randomly assigned to view an existing website about emergency contraception. The website contains information about the three methods of emergency contraception: the copper IUD, ulipristal pill, and levonorgestrel pill. It includes information about their relative effectiveness and where to access emergency contraception.	Other: Emergency contraception website; Existing website with factual information about emergency contraception
Other: Video about emergency contraception; Subjects are randomly assigned to view an existing video about emergency contraception. The video is two minutes in length and contains information about the three methods of emergency contraception: the copper IUD, ulipristal pill, and levonorgestrel pill. It includes information about their relative effectiveness and where to access emergency contraception.	Other: Emergency contraception video; Existing video with factual information about emergency contraception

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Emergency contraception knowledge (binary)	This outcome is a binary outcome that reflects a participant's ability to correctly identify an emergency contraceptive method, when to use it, and how to access it	Immediately after intervention

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Copper IUD as emergency contraception knowledge	This outcome is a binary outcomes that reflects a participant's ability to correctly identify the copper IUD as emergency contraception, when to use it, and how to access it.	Immediately after intervention
Levonorgestrel pill as emergency contraception knowledge	This outcome is a binary outcomes that reflects a participant's ability to correctly identify the levonorgestrel pill as emergency contraception, when to use it, and how to access it.	Immediately after intervention
Ulipristal pill as emergency contraception knowledge	This outcome is a binary outcomes that reflects a participant's ability to correctly identify the ulipristal pill as emergency contraception, when to use it, and how to access it.	Immediately after intervention
Emergency contraception knowledge (continuous)	This outcome reflects the participant's overall knowledge of emergency contraception after the website or video intervention, as measured by the proportion of questions they get correct on the survey	Immediately after intervention
Change in emergency contraception knowledge pre- and post-intervention	This outcome reflects the participant's change in knowledge of emergency contraception before and after the website or video intervention, as measured by the proportion of questions they get correct on the survey.	Immediately before and immediately after intervention
Likelihood of using emergency contraception pre- and post-intervention	This outcome reflects the participant's likelihood of using emergency contraception both before and after the intervention, as measured on a 6 point likert scale (I would definitely use it, Very likely, Somewhat likely, Somewhat unlikely, Very unlikely, I definitely would NOT use it)	Immediately before and immediately after intervention

Collaborators and Investigators

• Sponsor: Planned Parenthood League of Massachusetts
• Investigators: Principal Investigator: Principal Investigator, MD, Planned Parenthood League of Massachusetts

Study record dates

Study Major Dates

• Study Start (Actual): January 15, 2019
• Primary Completion (Actual): June 7, 2019
• Study Completion (Actual): June 7, 2019

Study Registration Dates

• First Submitted: December 11, 2018
• First Submitted That Met QC Criteria: December 11, 2018
• First Posted (Actual): December 13, 2018

Study Record Updates

• Last Update Posted (Actual): July 16, 2019
• Last Update Submitted That Met QC Criteria: July 15, 2019
• Last Verified: July 1, 2019

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Pathologic Processes; Disease Attributes; Emergencies
• Other Study ID Numbers: 2018P001764

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No